Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 44 | 2023 | 2084 | 3.060 |
Why?
|
Buprenorphine | 9 | 2022 | 665 | 1.850 |
Why?
|
Opioid-Related Disorders | 11 | 2024 | 2177 | 1.350 |
Why?
|
Smoking | 25 | 2022 | 9082 | 1.070 |
Why?
|
HIV Infections | 31 | 2023 | 17531 | 0.930 |
Why?
|
Counseling | 19 | 2022 | 1551 | 0.800 |
Why?
|
Tobacco Use Disorder | 9 | 2018 | 708 | 0.740 |
Why?
|
Tobacco Smoke Pollution | 7 | 2020 | 828 | 0.710 |
Why?
|
Inpatients | 9 | 2020 | 2563 | 0.680 |
Why?
|
Alcoholism | 2 | 2020 | 1978 | 0.640 |
Why?
|
Patient Discharge | 17 | 2022 | 3460 | 0.640 |
Why?
|
Warfarin | 8 | 2020 | 1494 | 0.530 |
Why?
|
Telephone | 8 | 2020 | 627 | 0.510 |
Why?
|
Salvia | 1 | 2015 | 13 | 0.490 |
Why?
|
Behavior, Addictive | 1 | 2020 | 423 | 0.480 |
Why?
|
Substance-Related Disorders | 6 | 2023 | 4418 | 0.480 |
Why?
|
Patient Education as Topic | 9 | 2020 | 2331 | 0.460 |
Why?
|
Health Promotion | 6 | 2022 | 2208 | 0.450 |
Why?
|
Nigeria | 9 | 2023 | 782 | 0.450 |
Why?
|
Sarcoma, Kaposi | 3 | 2021 | 376 | 0.420 |
Why?
|
CD4 Lymphocyte Count | 9 | 2016 | 2586 | 0.400 |
Why?
|
Opiate Substitution Treatment | 5 | 2024 | 452 | 0.380 |
Why?
|
Hospitalization | 13 | 2020 | 10810 | 0.370 |
Why?
|
Motivation | 4 | 2015 | 2018 | 0.370 |
Why?
|
Emigrants and Immigrants | 2 | 2016 | 550 | 0.370 |
Why?
|
Medication Adherence | 3 | 2020 | 2190 | 0.370 |
Why?
|
Choroid Neoplasms | 3 | 2001 | 175 | 0.360 |
Why?
|
Bupropion | 3 | 2020 | 303 | 0.350 |
Why?
|
Anti-HIV Agents | 6 | 2020 | 4558 | 0.350 |
Why?
|
Anti-Retroviral Agents | 4 | 2018 | 1786 | 0.350 |
Why?
|
Nicotine | 3 | 2013 | 680 | 0.340 |
Why?
|
Adult | 75 | 2024 | 223088 | 0.330 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2011 | 627 | 0.330 |
Why?
|
Naltrexone | 2 | 2022 | 319 | 0.320 |
Why?
|
Parents | 8 | 2020 | 3591 | 0.310 |
Why?
|
Occupational Health | 2 | 2012 | 812 | 0.310 |
Why?
|
HIV Seropositivity | 2 | 2013 | 961 | 0.300 |
Why?
|
Boston | 17 | 2024 | 9334 | 0.290 |
Why?
|
Ambulatory Care Facilities | 4 | 2020 | 937 | 0.290 |
Why?
|
Female | 94 | 2024 | 396141 | 0.290 |
Why?
|
Male | 85 | 2024 | 363815 | 0.290 |
Why?
|
Medical Informatics | 1 | 2014 | 743 | 0.280 |
Why?
|
Humans | 125 | 2024 | 765926 | 0.270 |
Why?
|
Middle Aged | 66 | 2024 | 223016 | 0.260 |
Why?
|
Continuity of Patient Care | 5 | 2017 | 1075 | 0.260 |
Why?
|
Patient Readmission | 1 | 2020 | 3282 | 0.260 |
Why?
|
Community Health Centers | 2 | 2024 | 469 | 0.260 |
Why?
|
Anticoagulants | 8 | 2020 | 4856 | 0.250 |
Why?
|
Physicians | 3 | 2014 | 4591 | 0.250 |
Why?
|
Atrial Fibrillation | 5 | 2020 | 5186 | 0.250 |
Why?
|
Program Development | 3 | 2022 | 1297 | 0.250 |
Why?
|
Mass Screening | 8 | 2019 | 5449 | 0.240 |
Why?
|
Community Health Services | 3 | 2020 | 657 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2705 | 0.230 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1121 | 0.230 |
Why?
|
Mobile Health Units | 2 | 2015 | 91 | 0.220 |
Why?
|
Ambulatory Care | 4 | 2024 | 2778 | 0.210 |
Why?
|
Referral and Consultation | 7 | 2022 | 3615 | 0.210 |
Why?
|
Automobiles | 2 | 2013 | 103 | 0.200 |
Why?
|
Hospitals, General | 4 | 2023 | 803 | 0.200 |
Why?
|
Aftercare | 4 | 2022 | 915 | 0.200 |
Why?
|
South Africa | 8 | 2017 | 1868 | 0.200 |
Why?
|
Weight Gain | 1 | 2012 | 2356 | 0.190 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2016 | 1899 | 0.190 |
Why?
|
Cohort Studies | 18 | 2024 | 41680 | 0.190 |
Why?
|
Hemorrhage | 5 | 2008 | 3466 | 0.190 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 949 | 0.190 |
Why?
|
Endorphins | 1 | 2021 | 73 | 0.190 |
Why?
|
Pediatrics | 5 | 2015 | 3609 | 0.190 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 100 | 0.180 |
Why?
|
Diffusion of Innovation | 1 | 2006 | 723 | 0.180 |
Why?
|
Methadone | 1 | 2023 | 318 | 0.180 |
Why?
|
Overweight | 1 | 2012 | 2444 | 0.180 |
Why?
|
Prevalence | 10 | 2022 | 15828 | 0.180 |
Why?
|
Obstetrics | 1 | 2008 | 679 | 0.180 |
Why?
|
Neoplasms | 9 | 2022 | 22340 | 0.180 |
Why?
|
Primary Health Care | 6 | 2020 | 4736 | 0.180 |
Why?
|
Temperance | 1 | 2020 | 88 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2016 | 4055 | 0.180 |
Why?
|
Hot Flashes | 2 | 2013 | 330 | 0.180 |
Why?
|
Methamphetamine | 1 | 2022 | 166 | 0.170 |
Why?
|
Viral Load | 4 | 2018 | 3385 | 0.170 |
Why?
|
Coagulants | 1 | 2020 | 45 | 0.170 |
Why?
|
Cotinine | 3 | 2020 | 206 | 0.170 |
Why?
|
Patient Selection | 4 | 2020 | 4248 | 0.170 |
Why?
|
Cardiovascular Diseases | 8 | 2018 | 15645 | 0.170 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2001 | 234 | 0.170 |
Why?
|
Eye Color | 1 | 1999 | 35 | 0.160 |
Why?
|
Factor VIIa | 1 | 2020 | 103 | 0.160 |
Why?
|
Electronic Health Records | 3 | 2022 | 4863 | 0.160 |
Why?
|
Attitude of Health Personnel | 2 | 2010 | 3928 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2022 | 260 | 0.150 |
Why?
|
Heroin | 1 | 2019 | 120 | 0.150 |
Why?
|
Hospitals, Teaching | 3 | 2012 | 1156 | 0.150 |
Why?
|
Hallucinogens | 1 | 2022 | 211 | 0.150 |
Why?
|
Physician-Patient Relations | 3 | 2010 | 3270 | 0.150 |
Why?
|
Behavior Therapy | 2 | 2022 | 886 | 0.150 |
Why?
|
Self Report | 5 | 2019 | 3768 | 0.150 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 372 | 0.150 |
Why?
|
Office Visits | 2 | 2016 | 594 | 0.140 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2020 | 409 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2023 | 81537 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 4 | 2016 | 3230 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 583 | 0.140 |
Why?
|
Alcohol-Related Disorders | 1 | 2019 | 242 | 0.140 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7423 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39228 | 0.140 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2020 | 663 | 0.130 |
Why?
|
Algorithms | 4 | 2014 | 14064 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10380 | 0.130 |
Why?
|
Massachusetts | 7 | 2020 | 8882 | 0.130 |
Why?
|
Colonoscopy | 1 | 2024 | 1408 | 0.130 |
Why?
|
HIV | 3 | 2020 | 1587 | 0.130 |
Why?
|
Fentanyl | 1 | 2019 | 451 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 446 | 0.130 |
Why?
|
Narcotic Antagonists | 1 | 2020 | 590 | 0.130 |
Why?
|
Attitude | 1 | 2020 | 768 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 904 | 0.130 |
Why?
|
Stroke | 6 | 2018 | 9739 | 0.120 |
Why?
|
Intention | 1 | 2018 | 346 | 0.120 |
Why?
|
Urban Health Services | 1 | 2016 | 176 | 0.120 |
Why?
|
Public Sector | 1 | 2017 | 264 | 0.120 |
Why?
|
Prenatal Care | 3 | 2008 | 1158 | 0.120 |
Why?
|
Workplace | 2 | 2012 | 873 | 0.120 |
Why?
|
Family Practice | 2 | 2010 | 508 | 0.120 |
Why?
|
Blood Glucose | 3 | 2012 | 6422 | 0.120 |
Why?
|
Aged | 30 | 2024 | 171163 | 0.120 |
Why?
|
Atrial Flutter | 1 | 2017 | 253 | 0.120 |
Why?
|
Young Adult | 19 | 2020 | 59857 | 0.120 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3834 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 809 | 0.120 |
Why?
|
Melanoma | 4 | 2001 | 5695 | 0.110 |
Why?
|
Health Care Surveys | 3 | 2010 | 2426 | 0.110 |
Why?
|
Feedback, Sensory | 1 | 2014 | 58 | 0.110 |
Why?
|
Time Factors | 12 | 2020 | 40097 | 0.110 |
Why?
|
Delivery of Health Care | 6 | 2020 | 5364 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2020 | 1171 | 0.110 |
Why?
|
Quality of Health Care | 4 | 2010 | 4305 | 0.110 |
Why?
|
Internship and Residency | 1 | 2014 | 5945 | 0.110 |
Why?
|
Competitive Behavior | 1 | 2014 | 77 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12059 | 0.110 |
Why?
|
Kenya | 3 | 2021 | 758 | 0.110 |
Why?
|
Reference Values | 3 | 2010 | 4909 | 0.110 |
Why?
|
Cholesterol | 2 | 2014 | 2902 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 427 | 0.110 |
Why?
|
Medically Underserved Area | 1 | 2015 | 267 | 0.110 |
Why?
|
Viremia | 1 | 2016 | 727 | 0.100 |
Why?
|
User-Computer Interface | 2 | 2011 | 1404 | 0.100 |
Why?
|
Multicenter Studies as Topic | 3 | 2024 | 1729 | 0.100 |
Why?
|
Risk Factors | 14 | 2018 | 74850 | 0.100 |
Why?
|
Logistic Models | 6 | 2015 | 13273 | 0.100 |
Why?
|
Hospitals | 3 | 2022 | 3886 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3444 | 0.100 |
Why?
|
Documentation | 2 | 2022 | 911 | 0.100 |
Why?
|
Pennsylvania | 3 | 2020 | 615 | 0.100 |
Why?
|
Outpatients | 2 | 2024 | 1595 | 0.100 |
Why?
|
Medical Records Systems, Computerized | 2 | 2011 | 1195 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1348 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2020 | 59496 | 0.090 |
Why?
|
International Normalized Ratio | 3 | 2020 | 382 | 0.090 |
Why?
|
Hypoparathyroidism | 1 | 2012 | 136 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2022 | 65194 | 0.090 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 4805 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7871 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2627 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1011 | 0.090 |
Why?
|
Self Medication | 1 | 2011 | 115 | 0.090 |
Why?
|
Mental Health Services | 1 | 2022 | 1729 | 0.090 |
Why?
|
Health Plan Implementation | 1 | 2013 | 337 | 0.090 |
Why?
|
Personnel, Hospital | 1 | 2012 | 285 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3238 | 0.080 |
Why?
|
Research Design | 3 | 2016 | 6204 | 0.080 |
Why?
|
Parent-Child Relations | 1 | 2014 | 772 | 0.080 |
Why?
|
Guideline Adherence | 2 | 2013 | 2234 | 0.080 |
Why?
|
Obesity | 2 | 2017 | 13082 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26282 | 0.080 |
Why?
|
Education, Distance | 1 | 2013 | 260 | 0.080 |
Why?
|
Data Mining | 1 | 2014 | 559 | 0.080 |
Why?
|
Linear Models | 2 | 2016 | 5873 | 0.080 |
Why?
|
Thiophenes | 1 | 2013 | 570 | 0.080 |
Why?
|
Telemedicine | 3 | 2022 | 3108 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3135 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1793 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2023 | 5300 | 0.070 |
Why?
|
Program Evaluation | 3 | 2015 | 2502 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1142 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3318 | 0.070 |
Why?
|
Adolescent | 19 | 2020 | 88811 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2012 | 12235 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 829 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2010 | 738 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1447 | 0.070 |
Why?
|
RNA, Viral | 1 | 2015 | 2866 | 0.070 |
Why?
|
Blood Pressure Determination | 1 | 2010 | 646 | 0.070 |
Why?
|
Incidence | 6 | 2020 | 21513 | 0.070 |
Why?
|
Depression | 3 | 2012 | 8223 | 0.070 |
Why?
|
Managed Care Programs | 3 | 2007 | 934 | 0.070 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 265 | 0.070 |
Why?
|
Health Surveys | 3 | 2012 | 4058 | 0.070 |
Why?
|
Health Policy | 3 | 2012 | 2699 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6958 | 0.070 |
Why?
|
Marital Status | 1 | 2008 | 426 | 0.070 |
Why?
|
Physical Fitness | 1 | 2010 | 742 | 0.070 |
Why?
|
Prescription Fees | 1 | 2007 | 153 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2007 | 642 | 0.060 |
Why?
|
Health Behavior | 2 | 2019 | 2649 | 0.060 |
Why?
|
Prospective Studies | 10 | 2024 | 54807 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 8060 | 0.060 |
Why?
|
Professional Practice | 1 | 2007 | 314 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15401 | 0.060 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5531 | 0.060 |
Why?
|
Menopause | 1 | 2013 | 1659 | 0.060 |
Why?
|
Language | 1 | 2014 | 1550 | 0.060 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2007 | 347 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2441 | 0.060 |
Why?
|
Registries | 3 | 2017 | 8346 | 0.060 |
Why?
|
Parity | 1 | 2008 | 931 | 0.060 |
Why?
|
Depression, Postpartum | 1 | 2009 | 354 | 0.060 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3477 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8721 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2008 | 365 | 0.060 |
Why?
|
Student Health Services | 1 | 2003 | 40 | 0.050 |
Why?
|
United States | 12 | 2020 | 72909 | 0.050 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 490 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2017 | 3000 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2008 | 619 | 0.050 |
Why?
|
Occult Blood | 1 | 2024 | 199 | 0.050 |
Why?
|
Physician's Role | 1 | 2010 | 925 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2014 | 2649 | 0.050 |
Why?
|
Medical Order Entry Systems | 1 | 2008 | 523 | 0.050 |
Why?
|
Internal Medicine | 1 | 2010 | 1064 | 0.050 |
Why?
|
Students | 2 | 2003 | 1741 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 947 | 0.050 |
Why?
|
Blood Pressure | 2 | 2018 | 8530 | 0.050 |
Why?
|
Angina, Unstable | 1 | 2006 | 893 | 0.050 |
Why?
|
Central Nervous System Agents | 1 | 2022 | 72 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 1319 | 0.050 |
Why?
|
Pregnant Women | 1 | 2007 | 576 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2013 | 2739 | 0.050 |
Why?
|
Quality of Life | 3 | 2018 | 13463 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9373 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 1001 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2013 | 2901 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5836 | 0.040 |
Why?
|
Postpartum Period | 1 | 2008 | 1195 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2001 | 236 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2710 | 0.040 |
Why?
|
Smoke | 1 | 2022 | 243 | 0.040 |
Why?
|
Radiotherapy, High-Energy | 1 | 2001 | 226 | 0.040 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 713 | 0.040 |
Why?
|
Tennessee | 1 | 2020 | 123 | 0.040 |
Why?
|
Educational Status | 1 | 2008 | 2510 | 0.040 |
Why?
|
Pancreatic Cyst | 1 | 2004 | 373 | 0.040 |
Why?
|
Anesthesiology | 1 | 2010 | 1133 | 0.040 |
Why?
|
Lost to Follow-Up | 1 | 2020 | 124 | 0.040 |
Why?
|
School Health Services | 1 | 2003 | 388 | 0.040 |
Why?
|
Kinetics | 1 | 2007 | 6273 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5509 | 0.040 |
Why?
|
Fees and Charges | 1 | 2020 | 189 | 0.040 |
Why?
|
Drug Costs | 1 | 2007 | 1194 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20133 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1696 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4882 | 0.040 |
Why?
|
Health Care Costs | 2 | 2012 | 3241 | 0.040 |
Why?
|
Length of Stay | 1 | 2012 | 6486 | 0.040 |
Why?
|
General Surgery | 1 | 2010 | 1722 | 0.040 |
Why?
|
Mothers | 1 | 2009 | 2206 | 0.040 |
Why?
|
Patient Dropouts | 1 | 2020 | 411 | 0.040 |
Why?
|
Child | 6 | 2020 | 80568 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6945 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4669 | 0.040 |
Why?
|
Protons | 2 | 2001 | 1073 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11508 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 2007 | 1662 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 751 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6321 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7842 | 0.040 |
Why?
|
Disclosure | 1 | 2023 | 756 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1377 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2008 | 2726 | 0.030 |
Why?
|
Botswana | 1 | 2020 | 1057 | 0.030 |
Why?
|
Prognosis | 4 | 2020 | 29890 | 0.030 |
Why?
|
Social Stigma | 1 | 2023 | 787 | 0.030 |
Why?
|
Uganda | 1 | 2021 | 1353 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15878 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 2050 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3360 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 852 | 0.030 |
Why?
|
Telemetry | 1 | 2017 | 201 | 0.030 |
Why?
|
Heparin | 1 | 2003 | 1632 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2000 | 2863 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30192 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12822 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21069 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 5889 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2020 | 1152 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1057 | 0.030 |
Why?
|
Body Mass Index | 2 | 2010 | 13042 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10727 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4855 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 12529 | 0.030 |
Why?
|
Age Factors | 4 | 2016 | 18382 | 0.030 |
Why?
|
Pregnancy | 4 | 2009 | 30230 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4851 | 0.030 |
Why?
|
Heart Failure | 2 | 2017 | 11837 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4527 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1631 | 0.030 |
Why?
|
Estrone | 1 | 2013 | 234 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2010 | 22228 | 0.030 |
Why?
|
Health Expenditures | 2 | 2020 | 2388 | 0.030 |
Why?
|
Lens, Crystalline | 1 | 1995 | 387 | 0.030 |
Why?
|
Self Care | 1 | 2017 | 800 | 0.020 |
Why?
|
Leuprolide | 1 | 2013 | 310 | 0.020 |
Why?
|
Radiation Injuries | 2 | 2000 | 1181 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.020 |
Why?
|
Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2242 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2017 | 770 | 0.020 |
Why?
|
Uveal Neoplasms | 1 | 1995 | 343 | 0.020 |
Why?
|
Risk Assessment | 4 | 2018 | 24275 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2013 | 731 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1813 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2013 | 828 | 0.020 |
Why?
|
Hospitals, Rural | 1 | 2012 | 175 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2012 | 494 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2844 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2004 | 0.020 |
Why?
|
Family Characteristics | 1 | 2015 | 1001 | 0.020 |
Why?
|
Dermatology | 1 | 2020 | 905 | 0.020 |
Why?
|
Environment | 1 | 2016 | 1119 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2270 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1971 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 499 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2339 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2015 | 717 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2010 | 152 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2017 | 1820 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2592 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11858 | 0.020 |
Why?
|
Medicare | 1 | 2007 | 6815 | 0.020 |
Why?
|
Thrombosis | 1 | 2003 | 2955 | 0.020 |
Why?
|
Child Welfare | 1 | 2013 | 521 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2008 | 113 | 0.020 |
Why?
|
Cataract | 1 | 1995 | 837 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 934 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3407 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2017 | 873 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2010 | 286 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2204 | 0.020 |
Why?
|
Geography | 1 | 2010 | 651 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14745 | 0.020 |
Why?
|
Vitamin D | 1 | 2021 | 3272 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1804 | 0.020 |
Why?
|
Cost Savings | 1 | 2012 | 900 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2008 | 12417 | 0.020 |
Why?
|
Polysomnography | 1 | 2013 | 1868 | 0.020 |
Why?
|
Sex Factors | 2 | 2014 | 10611 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11196 | 0.020 |
Why?
|
Estradiol | 1 | 2013 | 1947 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5450 | 0.020 |
Why?
|
Comorbidity | 2 | 2012 | 10575 | 0.020 |
Why?
|
Psychological Tests | 1 | 2008 | 642 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1640 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14643 | 0.010 |
Why?
|
Caregivers | 1 | 2017 | 2304 | 0.010 |
Why?
|
Urban Population | 1 | 2012 | 2040 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2040 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2759 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2915 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 418 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 642 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6409 | 0.010 |
Why?
|
Vitamin K | 1 | 2006 | 312 | 0.010 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2008 | 453 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 1 | 2004 | 336 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1394 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 895 | 0.010 |
Why?
|
Body Fluids | 1 | 2004 | 320 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2003 | 203 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3847 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2594 | 0.010 |
Why?
|
Rural Population | 1 | 2012 | 2318 | 0.010 |
Why?
|
Vitamin K 1 | 1 | 2001 | 41 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8522 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3690 | 0.010 |
Why?
|
Poverty | 1 | 2013 | 2714 | 0.010 |
Why?
|
Long-Term Care | 1 | 2005 | 630 | 0.010 |
Why?
|
Cobalt Radioisotopes | 1 | 2000 | 75 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 645 | 0.010 |
Why?
|
Time | 1 | 2002 | 549 | 0.010 |
Why?
|
Endosonography | 1 | 2004 | 626 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42510 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2474 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 3106 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1055 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2693 | 0.010 |
Why?
|
Infant | 2 | 2013 | 36426 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2248 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2936 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 869 | 0.010 |
Why?
|
Antifibrinolytic Agents | 1 | 2001 | 289 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2227 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6603 | 0.010 |
Why?
|
Sleep | 1 | 2013 | 4818 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2003 | 960 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8616 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8492 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7236 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2007 | 1945 | 0.010 |
Why?
|
Attitude to Health | 1 | 2003 | 2020 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81782 | 0.010 |
Why?
|
Risk | 1 | 2006 | 9599 | 0.010 |
Why?
|
Social Support | 1 | 2003 | 2190 | 0.010 |
Why?
|
Visual Fields | 1 | 2000 | 1062 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2000 | 1945 | 0.010 |
Why?
|
Visual Acuity | 1 | 2000 | 2670 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168735 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2008 | 26380 | 0.000 |
Why?
|
Radiotherapy | 1 | 1995 | 1491 | 0.000 |
Why?
|